Abstract
Aims: Hyperglycemia leads to elevation of oxidative stress and proinflammatory cytokines which are the main causes of diabetic nephropathy (DN). NLRP3 inflammasome and thioredoxin-interacting protein (TXNIP) are recently assumed to participate in the development of DN. We aimed to investigate the effects of Cepharanthine (CEP), Piperine (Pip) and their combination in streptozotocin (STZ)-induced DN focusing on their role to modulate NLRP3 and TXNIP induced inflammation.
Main methods: Diabetic rats were treated with intraperitoneal (i.p.) injection of CEP (10 mg/kg/day), Pip (30 mg/kg/day) or their combination for 8 weeks. Nuclear factor kappa B (NF-kappa B), tumor necrosis factor alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta) were assessed by ELISA technique. TXNIP and NLRP3 genes expressions were evaluated by real time-PCR.
Key findings: Diabetic rats showed significant increase in renal TXNIP and NLRP3 expression. CEP, Pip or their combination significantly decreased TXNIP and NLRP3 expression in diabetic kidneys. Hyperglycemia induced NF-kappa B activation leading to increased IL-1 beta and TNF-alpha levels. CEP, Pip or their combination showed significant inhibition of NF-kappa B together with decreased IL-1 beta and TNF-alpha levels in diabetic rats. Also, diabetic rats showed significant decrease in creatinine clearance and increase in blood glucose, serum creatinine, blood urea nitrogen, malondialdehyde, proteinuria, and kidney weight to body Weight ratio. All of these changes were reversed by CEP, Pip or their combination.
Significance: The antioxidant and anti-inflammatory effects of CEP and Pip which were accompanied by inhibition of NF-kappa B and NLRP3 activation might be helpful mechanisms to halt the progression of DN. (C) 2016 Elsevier Inc. All rights reserved.